What is Didanosine (ddI)?

Category: Prescription Drugs

Most popular types: Videx EC Videx

false

Didanosine (2',3'-dideoxyinosine, ddI) is sold under the trade names Videx and Videx EC. It is a reverse transcriptase inhibitor, effective against HIV and used in combination with other antiretroviral drug therapy as part of highly active antiretroviral therapy (HAART).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
3

Commonly reported side effects and conditions associated with Didanosine (ddI)

Side effect Patients

Why patients stopped taking Didanosine (ddI)

Multiple reasons could be selected

Reason Patients
Side effects too severe 2
Course of treatment ended 1
Did not seem to work 1
See all 5 patients who've stopped taking Didanosine (ddI)

Duration

Stopped taking Didanosine (ddI)

Duration Patients
6 months - 1 year 2
1 - 2 years 1
2 - 5 years 1
5 - 10 years 1
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 3
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 1
$50-99 1
$25-49 0
< $25 1
Not specified 0
Last updated:

1 patient evaluation for Didanosine (ddI)

Sep 5, 1996 (Started Oct 15, 1995)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 400 mg Daily
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Didanosine (ddI)